These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2866748)

  • 1. Pharmacological analysis of factors influencing platelet aggregation in stenosed coronary arteries of dogs.
    Aiken JW
    Ann N Y Acad Sci; 1985; 454():131-4. PubMed ID: 2866748
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
    Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of prostacyclins in acute coronary disease].
    Ogawa K; Ito T; Satake T
    Nihon Rinsho; 1983 Dec; 41(12):2795-802. PubMed ID: 6371302
    [No Abstract]   [Full Text] [Related]  

  • 5. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
    Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
    Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thromboxane and serotonin as mediators in the development of spontaneous alterations in coronary blood flow and neointimal proliferation in canine models with chronic coronary artery stenoses and endothelial injury.
    Willerson JT; Eidt JF; McNatt J; Yao SK; Golino P; Anderson HV; Buja LM
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):101B-110B. PubMed ID: 2016468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
    Schumacher WA; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboxane synthase inhibition and thromboxane/endoperoxide receptor antagonism in a chronic canine model of coronary thrombosis.
    Fitzgerald DJ; Fragetta J; Fenelon LC; FitzGerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():496-500. PubMed ID: 2959103
    [No Abstract]   [Full Text] [Related]  

  • 10. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW; Shebuski RJ; Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries.
    Bolli R; Brandon TA; Mace ML; Weibaecher DG
    Cardiovasc Res; 1985 Mar; 19(3):146-54. PubMed ID: 2859114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative effects of cigarette smoke and ethanol on acute platelet thrombus formation in stenosed canine coronary arteries.
    Keller JW; Folts JD
    Cardiovasc Res; 1988 Jan; 22(1):73-8. PubMed ID: 3167932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
    Torr S; Noble MI; Folts JD
    Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Tilton GD; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1983; 96():103-12. PubMed ID: 6687298
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.
    Honn KV; Menter DG; Onoda JM; Taylor JD; Sloane BF
    Symp Fundam Cancer Res; 1983; 36():361-88. PubMed ID: 6382514
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombin is an important mediator of cyclic coronary blood flow variations due to platelet aggregation in stenosed canine coronary arteries.
    Eidt JF; Allison P; Noble S; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    Trans Assoc Am Physicians; 1988; 101():125-36. PubMed ID: 3269674
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of prostacyclin and thromboxane A2 in the cardiovascular system].
    Ismailov ShI; Val'dman AV
    Kardiologiia; 1981 Mar; 21(3):111-6. PubMed ID: 7014974
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine.
    Folts JD; Bonebrake FC
    Circulation; 1982 Mar; 65(3):465-70. PubMed ID: 7055868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane synthetase inhibition results in increased platelet sensitivity to prostacyclin.
    Bertelé V; Falanga A; Roncaglioni MC; Cerletti C; de Gaetano G
    Thromb Haemost; 1982 Jun; 47(3):294. PubMed ID: 7051411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.